Notably, the KRASG12D mutation can promote the expression of UBE2C to promote cell cycle progression and autophagy in lung cancer, which indicated that UBE2C is an attractive carcinogenic genetic target for lung cancer with KRAS mutations [11]. Here, KRAS is linked to lung carcinoma.